5 recruiting. 3 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 3 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Medium Vessel Occlusion: new trials by email Literature Review of Medium Vessel Occlusion trials Research Report on Medium Vessel Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion Recombinant Tissue Plasminogen Activator (rt-PA), Intra-arterial Thrombolysis, Best Medical Management - Medium Vessel Occlusion, Ischemic Stroke, Acute | Phase 3 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 372 | 2026-09-19 | 2026-09-23 |
| PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Registry Management of Ischemic Stroke, Medium Vessel Occlusion | Recruiting | Indiana University | 652 | 2026-07-11 | 2026-08-05 | |
| Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke Intra-arterial Tenecteplase, standard medical management - Ischemic Stroke, Medium Vessel Occlusion | Phase 3 | Recruiting | Beijing Tiantan Hospital | 488 | 2026-01-22 | 2026-04-30 |
| Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion Intra-arterial Thrombolysis, Best Medical Treatment - Stroke, Cerebrovascular Disorders | Not applicable | Recruiting | The Second Hospital of Anhui Medical University | 282 | 2026-01-06 | 2026-04-16 |
| Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion Intra-arterial Thrombolysis, Standard medical treatment - Acute Ischemic Stroke, Medium Vessel Occlusion | Phase 2 / Phase 3 | Recruiting | Xiang Luo | 382 | 2025-12-30 | 2026-01-21 |
Ischemic Stroke (4) · Stroke (2) · Brain Diseases (1) · Cerebrovascular Disorders (1) · Constriction, Pathologic (1) · Infarction (1) · Nervous System Diseases (1) · Vascular Diseases (1)
Cardiovascular Diseases (5) · Central Nervous System Diseases (5) · Brain Diseases (4) · Cerebrovascular Disorders (4) · Nervous System Diseases (4) · Vascular Diseases (4) · Stroke (3) · Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Tenecteplase (1) · Tissue Plasminogen Activator (1)
Beijing Tiantan Hospital (1) · Indiana University (1) · The First Affiliated Hospital with Nanjing Medical University (1) · The Second Hospital of Anhui Medical University (1) · Xiang Luo (1)
China (4) · United States (1)
Kaustubh Limaye, MD, FAHA (1) · Qi Li, professor (1) · Sheng Liu, Professor (1) · Xiang Luo (1)
PMID 17702958, PMID 22343650, PMID 23223507, PMID 32486967, PMID 33070714, PMID 36279137, PMID 36862149, PMID 38787927, PMID 39264623, PMID 39908430, PMID 39908448, PMID 40616323